MLN1117

MLN1117 · Millennium Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MLN1117, covering 2019-09-20 to 2020-06-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer [Phase 2]

See pricing